Aker Biomarine A/S has attained Generally Recognized as Safe (GRAS) status for krill oil in foods.
Aker Biomarine A/S (Oslo, Norway) has announced that its Superba Krill Oil has received Generally Recognized as Safe (GRAS) status for use in food. The determination was made by a panel of independent experts who performed a critical review of toxicology studies on animals and humans supplementing with Superba.
Superba Krill Oil is a rich source of omega-3s DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid), and astaxanthin.
The company’s GRAS status for food ushers in the beginning of what could be an expanding market for Superba krill oil. (Today’s consumers are only familiar with the ingredient in dietary supplements.) Aker Biomarine says it is exploring functional food options in the United States and in Europe, where the ingredient holds Novel Foods status.
Superba Krill Oil is the only krill oil that holds Marine Stewardship Council certification for sustainable fishing practices.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.